Case Series — Descriptive Observational Study
Case Series Study · Also known as: case series report, clinical case series, consecutive case series, patient series
A case series is a descriptive observational study that documents the characteristics, clinical course, and outcomes of a group of patients who share a common condition, exposure, or intervention. Unlike case reports, which focus on a single patient, a case series aggregates data across multiple patients (typically three or more) to identify patterns, generate hypotheses, and characterize rare or novel conditions — without a concurrent control group.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
+6 more
When to use it
Use a case series when you need to describe the clinical features, course, or outcomes of a group of patients with a rare, novel, or poorly characterized condition — especially when controlled study designs are not yet feasible or ethical. It is the appropriate first-line design for documenting an outbreak of an emerging disease, characterizing unexpected adverse effects of a new therapy, or cataloguing presentations of a rare syndrome. Do not use a case series to establish causation, estimate incidence or prevalence in a population, or draw comparative conclusions between treatment arms — the absence of a control group makes all such inferences invalid. Analytical designs (cohort, case-control, RCT) are required for those goals.
Strengths & limitations
- Feasible for rare conditions where assembling a control group or achieving adequate sample size for an analytic study is impractical.
- Rapid to conduct using existing clinical records, making it valuable for hypothesis generation during emerging outbreaks or novel drug reactions.
- Provides granular, patient-level clinical detail that aggregate statistics obscure.
- Serves as the essential first step in the evidence hierarchy for conditions not previously described in the literature.
- No ethical barrier to participation since data come from routine clinical care.
- No control group means causal inference is impossible — observed outcomes may reflect natural disease history rather than any intervention.
- Prone to selection bias when cases are not identified consecutively or when reporting is driven by unusual or dramatic outcomes.
- Cannot estimate incidence, prevalence, or relative risk because the denominator population is undefined.
- Findings may not generalize beyond the specific clinical setting, time period, or case mix of the series.
- Retrospective case series are vulnerable to missing and incomplete data in clinical records.
Frequently asked
How many patients are needed for a case series?
There is no universally agreed minimum, but most methodologists distinguish a case series from a case report at three or more patients. Practically, larger series (10+ cases) carry more weight in hypothesis generation. The key is consecutive, unselected identification of all eligible cases rather than any specific sample size target.
Can a case series establish that a treatment works?
No. Without a control group it is impossible to know whether observed outcomes reflect the treatment, the natural history of the disease, regression to the mean, or concurrent care. A case series can support a plausible treatment effect sufficient to justify a controlled trial, but it cannot on its own confirm efficacy.
What is the difference between a case series and a cohort study?
A cohort study follows a defined population over time and compares outcomes between exposed and unexposed (or differently exposed) groups, enabling incidence and relative risk estimation. A case series describes only patients with the condition or exposure of interest — there is no comparison group and no population denominator, so incidence and comparative risk cannot be calculated.
How should I assess the quality of a published case series?
Key quality criteria include: a clear case definition applied consistently, consecutive patient identification (not cherry-picked), complete and uniform data collection, transparent reporting of follow-up duration and losses, and explicit acknowledgment of the lack of a control group. Tools such as the IHE Quality Appraisal Checklist for Case Series provide structured guidance.
When should I prefer a nested case-control design over a case series?
When you have access to a defined cohort and want to compare cases (patients who developed an outcome) with matched controls (patients who did not), a nested case-control design is preferable — it allows odds ratio estimation and controls for confounding. Use a case series when no cohort exists, the condition is too rare to assemble controls, or the goal is purely descriptive characterization.
Sources
How to cite this page
ScholarGate. (2026, June 3). Case Series Study. ScholarGate. https://scholargate.app/en/epidemiology/case-series
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Case-control studyEpidemiology↔ compare
- Cohort StudyEpidemiology↔ compare
- Cross-sectional epidemiological studyEpidemiology↔ compare
- Diagnostic Accuracy Study DesignClinical Research↔ compare
- Nested case-controlEpidemiology↔ compare